Regression of Left Ventricular Hypertrophy during Combined Atenolol and Nifedipine Treatment
- 6 Downloads
36 patients with previously untreated essential hypertension and left ventricular hypertrophy were treated with a fixed dose combination of atenolol 50mg and sustained release nifedipine 20mg once daily for a mean period of 12.1 months. Echocardiography showed a significant decrease after a mean period of 7.9 months in interventricular septal thickness (13.6%, p < 0.01), posterior wall thickness (12.6%, p < 0.001) and left ventricular mass index (18.3%). After 12.1 months the reductions were 20.7% (p < 0.001), 22.5% (p < 0.001) and 30.8% (p < 0.001), respectively. Posterior wall thickness was significantly reduced, but left ventricular end-systolic and end-diastolic dimensions and fractional shortening remained unchanged. Treatment significantly reduced resting blood pressure from 153/105mm Hg to 122/79mm Hg (p < 0.001), and exercise blood pressure at 100 W from 189/109 to 157/93mm Hg (p < 0.001). Thus, nifedipine in combination with atenolol produces significant blood pressure reduction accompanied by regression of left ventricular hypertrophy without noticeable changes in left ventricular function.
KeywordsNifedipine Atenolol Left Ventricular Hypertrophy Ventricular Hypertrophy Left Ventricular Mass Index
Unable to display preview. Download preview PDF.
- Corea L, Bentivoglio M, Verdecchia P, Provvidenza M, Motolese M. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. International Journal of Clinical Pharmacology, Therapy and Toxicology 22: 365–370, 1984Google Scholar
- Franz IW. The effects of prazosin and acebutolol and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients. Zeitschrift für Kardiologie 72: 746–754, 1983Google Scholar
- Franz IW. Ergometry in hypertensive patients. Springer Verlag, Berlin, 1985Google Scholar
- Franz IW, Wiewel D. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, β-receptor blockers, and their combination in hypertensive patients. Journal of Cardiovascular Pharmacology 6(Suppl. 7): 1037–1042, 1984Google Scholar
- Franz IW, Tönnesmann U, Behr U, Ketelhut R. Long-term effect of antihypertensive therapy on left ventricular hypertrophy. Journal of Hypertension, in pressGoogle Scholar